Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
2010 · Clinical Breast Cancer · 90 citations
https://doi.org/10.3816/cbc.2010.n.036